
Bioorganic and Medicinal Chemistry Letters p. 2241 - 2246 (1998)
Update date:2022-08-05
Topics:
Sakaki, Junichi
Murata, Toshiki
Yuumoto, Yoko
Nakamura, Ikushi
Frueh, Thomas
Pitterna, Thomas
Iwasaki, Genji
Oda, Kyoko
Yamamura, Takaki
Hayakawa, Kenji
IRL 3461, N-butanesulfonyl-[N-(3,5-dimethylbenzoyl)-N-methyl-3-[4-(5- isoxazolyl)-phenyl]-alanyl]-(L)-valineamide, a potent and bifunctional (ET(A) + ET(B)) [Ki(ET(A))=1.8 nM, Ki(ET(B))=1.2 nM] antagonist was discovered by structural modification of IRL 2500, an ET(B) selective antagonist. IRL 3461 was found to be stable on incubation with human, rat, mouse, and guinea pig plasmas.
View MoreAnhui Redstar Pharmaceutical Corp., Ltd
Contact:+86-563-5120837
Address:Jingxian Industrial Development Zone, Anhui , China
Chengdu Boon Stream Chemical Industry Co.,Ltd.
Contact:+86-28-83156758
Address:No.859,Dongzikou Road,Jinniu District,Chengdu,Sichuan,P.R.China
Contact:021-36356756
Address:Room601,Building No.14,280 Yangcheng Road,Shanghai
Cerametek Materials(ShenZhen)Co., Ltd.
Contact:+86-755-2324.2554
Address:A3-#9, YongChuan Street, Suite 501
hangzhou verychem science and technology co.ltd
website:http://www.verypharm.com
Contact:+86-571-88162785; 88162786
Address:F1502, 753 Shenhua road, Hangzhou, China
Doi:10.1016/S0040-4039(96)02032-1
(1996)Doi:10.1021/jo961168z
(1997)Doi:10.1016/S0040-4020(99)00444-5
(1999)Doi:10.1002/anie.201703174
(2017)Doi:10.1016/j.tet.2016.08.001
(2016)Doi:10.1139/v96-244
(1996)